Editor’s note: This is a recent installment in a series of employee profiles being published by the U.S. Department of Agriculture’s Food Safety Inspection Service, republished here
Three New York seafood importers are on notice from the Food and Dr
ug Administration for violations of the Seafood Hazard Analysis and Critical Control Point (HACCP) regulation in addition
A seafood processor in Panama, and a ready-to-eat food manufacturer in Tennessee are both on notice from the Food and Drug Administration for violations of federal food safety rules.
The
After sickening more than 30 people with E. coli O157:H7 – including several kids with acute kidney failure – you would think that all this tainted product would be off the
Ready-to-eat, smoked fish and fishery products produced by Michel Cordon Bleu Inc. in Los Angeles from such raw fish as Florida salmon and Idaho trout and sold to restaurants, retailers,
A South Carolina ice pop manufacturer and
an Oregon low-acid canned food producer are both on notice from the Food and Drug Administration for violations of federal food safety rules.
In the first provincial court case prosecuted in Canada for misrepresentation of a kosher food product, Creation Foods Co. of Woodbridge, has been fined $25,000.
The corporate entity recently
Food safety concerns are at an all-time high and the global food industry is facing a raft of new regulations, including more frequent inspections and possibly higher compliance costs. The
Health officials say they’re sure food from a specific vendor at the Rifle Rodeo in Garfield County, CO, caused an outbreak that sickened 40 percent of attendees, but they
A food warehouse and repacking facility, a bakery, a dietary supplement repacking facility and an airport are all on notice from the Food and Drug Administration for violations of the
Neither management nor employees at a New Jersey food manufacturing plant understand the basics of food safety, according to federal officials who described conditions at Products Africana Inc. as “egregious”
Editor’s note: This column was originally published by the Food and Drug Administration as a Voice Blog.
We have made dramatic changes in our response to complex, potentially high-risk